Table 3.
Multivariate Cox proportional hazard analysis of 1 SD increase in the change of different lipid components and ratios, for incident type 2 diabetes, Tehran Lipid and Glucose Study (1999–2015)
| Lipid parameters | Hazard ratio (95% CI) |
P-value | AIC | Harrell’s C |
|---|---|---|---|---|
| TC (mmol/L) | ||||
| Model 1 | 1.11(1.02–1.21) | 0.019 | 9489 | 0.65 |
| Model 2 | 1.15 (1.05–1.26) | 0.003 | 9043 | 0.78 |
| Model 3 | 1.12(1.02–1.23) | 0.018 | 9025 | 0.78 |
| Model 4 | 0.999(0.91–1.10) | 0.99 | 8840 | 0.81 |
| LnTG | ||||
| Model 1 | 1.20(1.10–1.31) | < 0.001 | 9399 | 0.69 |
| Model 2 | 1.18(1.08–1.29) | < 0.001 | 9021 | 0.78 |
| Model 3 | 1.14(1.03–1.25) | 0.008 | 9003 | 0.79 |
| Model 4 | 1.09(0.99–1.20) | 0.09 | 8821 | 0.81 |
| HDL-C (mmol/L) | ||||
| Model 1 | 0.80(0.72–0.88) | < 0.001 | 9486 | 0.65 |
| Model 2 | 0.85(0.77–0.94) | 0.001 | 9041 | 0.78 |
| Model 3 | 0.86(0.78–0.95) | 0.003 | 9021 | 0.78 |
| Model 4 | 0.84(0.76–0.93) | 0.001 | 8831 | 0.81 |
| LDL-C (mmol/L) | ||||
| Model 1 | 1.11(1.02–1.22) | 0.016 | 9499 | 0.65 |
| Model 2 | 1.14(1.04–1.25) | 0.004 | 9045 | 0.78 |
| Model 3 | 1.12(1.02–1.23) | 0.018 | 9026 | 0.78 |
| Model 4 | 1.01(0.92–1.11) | 0.81 | 8842 | 0.81 |
| Non-HDL-C (mmol/L) | ||||
| Model 1 | 1.16(1.06–1.26) | 0.001 | 9474 | 0.66 |
| Model 2 | 1.20(1.09–1.31) | < 0.001 | 9035 | 0.78 |
| Model 3 | 1.16(1.06–1.27) | 0.001 | 9019 | 0.78 |
| Model 4 | 1.04(0.95–1.15) | 0.38 | 8839 | 0.81 |
| LnTG/HDL-C | ||||
| Model 1 | 1.23(1.13–1.35) | < 0.001 | 9408 | 0.68 |
| Model 2 | 1.19(1.09–1.31) | < 0.001 | 9021 | 0.78 |
| Model 3 | 1.15(1.05–1.26) | 0.002 | 9004 | 0.79 |
| Model 4 | 1.14(1.04–1.25) | 0.007 | 8822 | 0.81 |
| TC/HDL-C | ||||
| Model 1 | 1.21(1.13–1.29) | < 0.001 | 9461 | 0.66 |
| Model 2 | 1.15(1.07–1.23) | < 0.001 | 9036 | 0.78 |
| Model 3 | 1.13(1.06–1.22) | 0.001 | 9018 | 0.78 |
| Model 4 | 1.12(1.04–1.21) | 0.003 | 8833 | 0.81 |
TC: total cholesterol; TG: triglycerides; HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, CI: confidence interval, AIC: Akaike's information criteria
Model 1: adjusted for age, sex, and baseline measurements of lipid profile
Model 2: adjusted for age sex, education, lipid drug use, family history of type 2 diabetes, history of cardiovascular disease, hypertension and baseline measurements of fasting plasma glucose (FPG), body mass index (BMI), waist circumferences (WC) and lipid profile
Model 3: model 2+ BMI change
Model 4: model 3+ FPG change